The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 2017

Filed:

Aug. 27, 2013
Applicant:

Asterias Biotherapeutics, Inc., Fremont, CA (US);

Inventors:

Ramkumar Mandalam, Union City, CA (US);

Saadia Faouzi, Daly City, CA (US);

Isabelle Nadeau, San Francisco, CA (US);

Kristina Pfendler-Bonham, South San Francisco, CA (US);

Namitha Rao, San Jose, CA (US);

Melissa K. Carpenter, London, CA (US);

Lakshmi Rambhatla, Redwood City, CA (US);

Choy-Pik Chiu, Cupertino, CA (US);

Assignee:

Asterias Biotherapeutics, Inc., Fremont, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
C12N 5/067 (2013.01); C12N 2500/30 (2013.01); C12N 2500/36 (2013.01); C12N 2500/62 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/119 (2013.01); C12N 2501/12 (2013.01); C12N 2501/13 (2013.01); C12N 2501/148 (2013.01); C12N 2501/155 (2013.01); C12N 2501/23 (2013.01); C12N 2501/33 (2013.01); C12N 2501/335 (2013.01); C12N 2501/385 (2013.01); C12N 2501/39 (2013.01); C12N 2502/13 (2013.01); C12N 2503/02 (2013.01); C12N 2506/02 (2013.01); C12N 2533/90 (2013.01); C12N 2533/92 (2013.01);
Abstract

This disclosure provides a newly developed strategy and particular options for differentiating pluripotent stem cells into cells of the hepatocyte lineage. Many of the protocols are based on a strategy in which the cells are first differentiated into early germ layer cells, then into hepatocyte precursors, and then into mature cells. The cells obtained have morphological features and phenotypic markers characteristic of human adult hepatocytes. They also show evidence of cytochrome p450 enzyme activity, validating their utility for commercial applications such as drug screening, or use in the manufacture of medicaments and medical devices for clinical therapy.


Find Patent Forward Citations

Loading…